Sage Journals: Discover world-class research

Free access

Review article

First published 2014-9

Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential

Parvin F. Peddi, Sara A. Hurvitz

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15)

Sun Kyung Baek, Jae-ho Jeong, KyungHae Jung [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2021-12

Cardiotoxicity of trastuzumab emtansine (T-DM1): a single-center experience

Aynur Acibuca, Ahmet Sezer, Mustafa Yilmaz [...]

Journal of International Medical Research

Retricted access

Research article

First published 2019-05

Imaging of HER2 with [ 89 Zr]pertuzumab in Response to T-DM1 Therapy

Adriana V.F. Massicano, Supum Lee, Bryant K. Crenshaw [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Research article

First published 2025

The mechanisms of HER2 targeted ADCs are dependent on Rab GTPases

Astrid Medhus, Kay Oliver Schink, Ane Sager Longva [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2015-4

Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer

Jessica M Baron, Bonnie L Boster, Chad M Barnett

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2025-2

Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancer

Oğuzhan Yıldız, Ali Fuat Gürbüz, Melek Karakurt Eryılmaz [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2022-6

Ado-trastuzumab emtansine associated spider telangiectasia

Pınar Gursoy, Ayda Acar, Taner Acikalin

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2021

PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting

Laura Pizzuti, Eriseld Krasniqi, Isabella Sperduti [...]

Therapeutic Advances in Medical Oncology

Free access

Review article

First published 2012-9

The potential for trastuzumab emtansine in human epidermal growth factor receptor 2 positive metastatic breast cancer: latest evidence and ongoing studies

Sara A. Hurvitz, Reva Kakkar

Therapeutic Advances in Medical Oncology

Search results